School of Medicine
Showing 1-20 of 33 Results
-
Imelda Balboni
Clinical Associate Professor, Pediatrics - Rheumatology
Current Research and Scholarly InterestsPediatric systemic lupus erythematosus;
Autoimmune disease;
Proteomics and autoantigen microarray technology -
Jennifer Frankovich
Clinical Professor, Pediatrics - Rheumatology
Current Research and Scholarly InterestsMy primary interest and role at Stanford is to evaluate and treat children with both systemic and organ specific autoimmune disease. In October of 2012, we started a multidisciplinary clinic dedicated to treating patients with PANS (Pediatric Acute-onset Neuropsychiatric Syndromes). I am currently the clinical and research director for the PANS program.
-
Jacquelyn Horgan
Program Manager, Pediatrics - Rheumatology
Current Role at StanfordProgram Manager for the Immune Behavioral Health/PANS Clinical Research Program
-
Joyce Hsu
Clinical Associate Professor, Pediatrics - Rheumatology
Current Research and Scholarly InterestsPediatric Systemic Lupus Erythematosus;
Lupus Nephritis;
Racial/Ethnic Differences in Pediatric Lupus Patients
CARRA Registry -
Siva Kasinathan
Fellow in Pediatrics - Rheumatology
BioSiva Kasinathan, MD, PhD is a Clinical Fellow in Pediatric Rheumatology at the Stanford University School of Medicine and Lucile Packard Children’s Hospital at Stanford. His graduate research in the MD-PhD program at the University of Washington included the innovation of genome-scale methods for chromatin profiling and generated new insights in centromere biology and gene regulation. During his clinical training in pediatrics at Stanford, Siva continued develop genomic technologies, this time with a focus on single-molecule sequencing. Siva’s research interests span genetics, epigenomics, and immune dysregulation. His ongoing work with Dr. Ansu Satpathy involves developing and applying sensitive new methods for analyzing immunogenetic variation in lupus. As a physician-scientist, Siva is committed combining clinical medicine and basic and translational research to better understand the molecular mechanisms of autoimmunity and autoinflammation to improve outcomes for patients with rheumatic diseases.
